Colorectal Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colorectal Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 4 (2007), Issue 9 (September)

1. CD44 regulates cell migration in human colon cancer cells via Lyn kinase and AKT phosphorylation.
   Exp Mol Pathol, 83(2): 207-15. [Abstract] [Full-text]
2. Classification based on the combination of molecular and pathologic predictors is superior to molecular classification on prognosis in colorectal carcinoma.
   Clin Cancer Res, 13(17): 5082-8. [Abstract] [Full-text]
3. Overexpression of FLIPL is an independent marker of poor prognosis in colorectal cancer patients.
   Clin Cancer Res, 13(17): 5070-5. [Abstract] [Full-text]
4. Screening preferences of patients at familial risk of colorectal cancer.
   Dig Dis Sci, 52(10): 2788-95. [Abstract] [Full-text]
5. Comfort and efficacy of a longer and thinner endoscope for average risk colon cancer screening.
   Dig Dis Sci, 52(10): 2892-6. [Abstract] [Full-text]
6. Inflammatory cytokines stimulate the adhesion of colon carcinoma cells to mesothelial monolayers.
   Dig Dis Sci, 52(10): 2775-83. [Abstract] [Full-text]
7. Malignancy risk of small polyps and related factors.
   Dig Dis Sci, 52(10): 2796-9. [Abstract] [Full-text]
8. Pro-apoptotic PUMA and anti-apoptotic phospho-BAD are highly expressed in colorectal carcinomas.
   Dig Dis Sci, 52(10): 2751-6. [Abstract] [Full-text]
9. Understanding variation in the management of rectal cancer: the potential of a surgeon-initiated database.
   Am J Surg, 194(4): 559-62. [Abstract] [Full-text]
10. The 4-portal technique decreases adverse effects in preoperative radiotherapy for advanced rectal cancer: comparison between the 2-portal and the 4-portal techniques.
    Am J Surg, 194(4): 542-8. [Abstract] [Full-text]
11. Cationized catalase-loaded hydrogel for growth inhibition of peritoneally disseminated tumor cells.
    J Control Release, 122(2): 151-8. [Abstract] [Full-text]
12. Frequency of colorectal cancer screening and the impact of family physicians on screening behaviour.
    CMAJ, 177(6): 593-7. [Abstract] [Full-text]
13. Inhibition of p38/CREB phosphorylation and COX-2 expression by olive oil polyphenols underlies their anti-proliferative effects.
    Biochem Biophys Res Commun, 362(3): 606-11. [Abstract] [Full-text]
14. Benefit from preoperative radiotherapy in rectal cancer treatment: disease-free patients' and oncologists' preferences.
    Br J Cancer, 97(6): 717-24. [Abstract] [Full-text]
15. Identification of consensus genes and key regulatory elements in 5-fluorouracil resistance in gastric and colon cancer.
    Onkologie, 30(8): 421-6. [Abstract] [Full-text]
16. In vitro evaluation of cancer-specific NF-kappaB-CEA enhancer-promoter system for 5-fluorouracil prodrug gene therapy in colon cancer cell lines.
    Br J Cancer, 97(6): 745-54. [Abstract] [Full-text]
17. Reovirus decreases azoxymethane-induced aberrant crypt foci and colon cancer in a rodent model.
    Cancer Gene Ther, 14(10): 867-72. [Abstract] [Full-text]
18. Colorectal cancer screening in elderly patients: when should be more useful?
    Cancer Treat Rev, 33(6): 528-32. [Abstract] [Full-text]
19. The paracrine hormone hypothesis of colorectal cancer.
    Clin Pharmacol Ther, 82(4): 441-7. [Abstract] [Full-text]
20. Somatic APC mosaicism: a frequent cause of familial adenomatous polyposis (FAP).
    Hum Mutat, 28(10): 985-92. [Abstract] [Full-text]
21. Comment on "The consensus coding sequences of human breast and colorectal cancers".
    Science, 317(5844): 1500. [Abstract] [Full-text]
22. Comment on "The consensus coding sequences of human breast and colorectal cancers".
    Science, 317(5844): 1500. [Abstract] [Full-text]
23. Comment on "The consensus coding sequences of human breast and colorectal cancers".
    Science, 317(5844): 1500; author reply 1500. [Abstract] [Full-text]
24. The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancer.
    Gut, 56(10): 1426-32. [Abstract] [Full-text]
25. Preoperative therapy for lower rectal cancer and modifications in distance from anal sphincter.
    Int J Radiat Oncol Biol Phys, 69(2): 370-5. [Abstract] [Full-text]
26. Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathology.
    Gut, 56(10): 1419-25. [Abstract] [Full-text]
27. Evaluation of a card collection-based faecal immunochemical test in screening for colorectal cancer using a two-tier reflex approach.
    Gut, 56(10): 1415-8. [Abstract] [Full-text]
28. Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instability.
    J Clin Oncol, 25(27): 4231-8. [Abstract] [Full-text]
29. Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study Group.
    J Clin Oncol, 25(27): 4217-23. [Abstract] [Full-text]
30. Phase III study of capecitabine plus oxaliplatin compared with continuous-infusion fluorouracil plus oxaliplatin as first-line therapy in metastatic colorectal cancer: final report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial.
    J Clin Oncol, 25(27): 4224-30. [Abstract] [Full-text]
31. Inhibition of COX-2 with NS-398 decreases colon cancer cell motility through blocking epidermal growth factor receptor transactivation: possibilities for combination therapy.
    Cell Prolif, 40(5): 768-79. [Abstract] [Full-text]
32. Operative probe scintimetry with indium and technetium for colorectal cancer.
    J Surg Oncol, 96(4): 290-6. [Abstract] [Full-text]
33. Radioimmunoguided surgery (RIGS), PET/CT image-guided surgery, and fluorescence image-guided surgery: past, present, and future.
    J Surg Oncol, 96(4): 297-308. [Abstract] [Full-text]
34. Expression and characterization of a human carboxylesterase 2 splice variant.
    J Pharmacol Exp Ther, 323(1): 94-101. [Abstract] [Full-text]
35. Anus-preservation treatment for anal cancer: retrospective analysis at a single institution.
    J Surg Oncol, 96(5): 374-80. [Abstract] [Full-text]
36. Hepatectomy and lung radiofrequency ablation for hepatic and subsequent pulmonary metastases from colorectal carcinoma.
    J Surg Oncol, 96(5): 367-73. [Abstract] [Full-text]
37. Nitrates in drinking water and risk of death from rectal cancer in Taiwan.
    J Toxicol Environ Health A, 70(20): 1717-22. [Abstract] [Full-text]
38. Anatomic factors predictive of incomplete colonoscopy based on findings at CT colonography.
    AJR Am J Roentgenol, 189(4): 774-9. [Abstract] [Full-text]
39. Computer-aided detection (CAD) using 360 degree virtual dissection: can CAD in a first reviewer paradigm be a reliable substitute for primary 2D or 3D search?
    AJR Am J Roentgenol, 189(4): W172-6. [Abstract] [Full-text]
40. Human papillomavirus in lesions of anogenital mammary-like glands.
    Int J Gynecol Pathol, 26(4): 475-80. [Abstract] [Full-text]
41. Genomic profiling of circulating plasma RNA for the analysis of cancer.
    Clin Chem, 53(10): 1860-3. [Abstract] [Full-text]
42. A population-based study of radiotherapy in a cohort of patients with rectal cancer diagnosed between 1996 and 2000.
    Eur J Surg Oncol, 33(8): 993-7. [Abstract] [Full-text]
43. Selective continuous vascular occlusion and perioperative fluid restriction in partial hepatectomy. Outcomes in 101 consecutive patients.
    Eur J Surg Oncol, 33(8): 1036-41. [Abstract] [Full-text]
44. Predictors of early disease recurrence following hepatic resection for colorectal cancer metastasis.
    Eur J Surg Oncol, 33(8): 1003-9. [Abstract] [Full-text]
45. Incidence and prognostic influence of lymph node micrometastases in rectal cancer.
    Eur J Surg Oncol, 33(8): 998-1002. [Abstract] [Full-text]
46. The impact of staging laparoscopy prior to hepatic resection for colorectal metastases.
    Eur J Surg Oncol, 33(8): 1010-3. [Abstract] [Full-text]
47. Effective second-line treatment with cetuximab and bevacizumab in a patient with hepatic metastases of colorectal cancer and hyperbilirubinemia.
    Onkologie, 30(10): 509-12. [Abstract] [Full-text]
48. Angiocidin inhibitory peptides decrease tumor burden in a murine colon cancer model.
    J Surg Res, 142(2): 320-6. [Abstract] [Full-text]
49. A vitamin D analogue inhibits colonic carcinogenesis in the AOM/DSS model.
    J Surg Res, 142(2): 239-45. [Abstract] [Full-text]
50. Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial.
    Ann Surg, 246(4): 655-62; discussion 662-4. [Abstract] [Full-text]
51. Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial.
    Ann Surg, 246(4): 568-75; discussion 575-7. [Abstract] [Full-text]
52. Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines.
    Cancer, 110(7): 1469-77. [Abstract] [Full-text]
53. Improving colorectal cancer screening by using community volunteers: results of the Carolinas cancer education and screening (CARES) project.
    Cancer, 110(7): 1602-10. [Abstract] [Full-text]
54. Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease.
    JAMA, 298(12): 1412-9. [Abstract] [Full-text]
55. DNA damage induced by novel demethylcantharidin-integrated platinum anticancer complexes.
    Biochem Biophys Res Commun, 363(1): 235-40. [Abstract] [Full-text]

© 2004-2008 Colorectal Cancer Research Today. All Rights Reserved.